Fecal Carriage of Multidrug-Resistant Staphylococcus aureus in Hypertensive Patients at the Douala Laquintinie Hospital: Prevalence and Resistance Patterns

杜阿拉拉昆蒂尼医院高血压患者粪便中多重耐药金黄色葡萄球菌的携带情况:流行率和耐药模式

阅读:1

Abstract

Patients with hypertension may be more susceptible to acquiring Staphylococcus aureus (S. aureus) infections, according to some studies. Hypertension and certain antihypertensive drugs predispose to multidrug-resistant bacteria. The present study, carried out at the Laquintinie Hospital in Douala, is aimed at determining the antibiotic-resistant profile of fecal carriage S. aureus in hypertensive patients and their association with hypertension. This was a cross-sectional study that was carried out from June 2022 to June 2023. Five hundred and eighteen (518) stool samples were collected, from which the isolation of S. aureus was made using mannitol salt agar. Mannitol fermentation, catalase, and coagulase tests were used for species identification. The Kirby-Bauer disc diffusion method was used for the antibiotic susceptibility assay. Our study revealed that the frequency of fecal carriage of S. aureus was significantly higher in hypertensive participants (65.15%, n = 43) compared to nonhypertensive participants (34.85%, n = 23). The frequency of fecal carriage of methicillin-resistant S. aureus (MRSA) was significantly higher in participants with hypertension compared to nonhypertensive participants (88.37% vs. 47.83%, p ~ 0.001). The antibiotic susceptibility test revealed that the resistance of S. aureus to fusidic acid, cotrimoxazole, and oxacillin was significantly higher in hypertensive than in nonhypertensive patients. There was a significant association between hypertension and S. aureus resistance to oxacillin (OR = 8.29, p ~ 0.001) and trimethoprim-sulfamethoxazole (OR = 6.07, p = 0.001). In addition, S. aureus isolates showed high resistance rates in treated hypertensive participants compared to untreated hypertensive participants. This study reveals that S. aureus exhibits high resistance to many of the clinically used antimicrobials. The need for appropriate antibiotic use to halt, or at least limit, the spread of resistance is suggested in the care of hypertensive patients with enteric infection caused by S. aureus.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。